基本信息 产品详情 公司简介 推荐产品
网站主页 HUMAN白介素13(IL13) ELISA KIT IL-13试剂盒
  • IL-13 ELISA试剂盒-ACROBiosystems百普赛斯
  • IL-13 ELISA试剂盒-ACROBiosystems百普赛斯
  • IL-13 ELISA试剂盒-ACROBiosystems百普赛斯

1/3

IL-13 ELISA试剂盒-ACROBiosystems百普赛斯

IL-13 ELISA Kit
询价 1支 起订
5支 起订
10支 起订
北京 更新日期:2024-11-21

北京百普赛斯生物科技股份有限公司

VIP1年
联系人:姚经理
手机:18514007688 拨打
邮箱:jiaxin.zhao@acrobiosystems.com

产品详情:

中文名称:
IL-13试剂盒
英文名称:
IL-13 ELISA Kit
品牌:
百普赛斯
产地:
北京
保存条件:
-20°C to -70°C
纯度规格:
99.9%
产品类别:
ELISA试剂盒
数量:
999
保质期:
12个月
货号:
EP-149
是否进口:
适应物种:
Human

IL-13RA2 [Biotinylated] : IL-13 Inhibitor Screening ELISA Kit

1.jpg

背景(Background

Interleukin-13 receptor subunit alpha-2 is also known as IL13Rα2, IL13Ra2 cluster of differentiation 213A2, CD213A2, CT19, IL-13R, IL13BP, and is a membrane bound protein that in humans is encoded by the IL13RA2 gene. IL13Rα2 is closely related to IL13Rα1, a subunit of the interleukin-13 receptor complex. This protein binds IL13 with high affinity, but lacks any significant cytoplasmic domain, and does not appear to function as a signal mediator. It is, however able to regulate the effects of both IL13 and IL4, despite the fact it is unable to bind directly to the latter. It is also reported to play a role in the internalization of IL13. IL13Rα2 is a component of the cell surface receptors, however, the majority exists in intracellular pools and in soluble form, and thus plays an opposite role as a potent IL13 antagonist compared with IL13Rα1. It also functions as an inhibitor of IL4-dependent pathway probably through the physical interaction between the short intracellular domain of and cytoplasmic domain of IL13Rα2 and the IL4Rα chain. In spite of the failed STAT signaling function, IL13Rα2 dose induce TGF-beta production and fibrosis. Additionally, IL13Rα2has been reported to be abundantly and specifically overexpressed in glioblastoma multiforme.

原理(Assay Principles

This inhibitor screening ELISA kit is designed to facilitate the identification and characterization of new IL-13 R alpha 2 pathway inhibitors. The assay takes advantage of our in house-developed binding of biotinylated human IL-13 R alpha 2 to immobilized human IL-13 in a functional ELISA assay, and employs a simple colorimetric ELISA platform. Briefly, we provide you with a human Biotinylated IL-13 R alpha 2 protein, a human IL-13 protein, an anti-IL-13 R alpha 2 neutralizing antibody (as method verified Std.), and Streptavidin-HRP reagent.

Your experiment will include 4 simple steps:

a) Coat the plate with human IL-13.

b) Add your molecule of interest to the tests.

c) Add human IL-13 R alpha 2-Biotin to bind the coated IL-13.

d) Add Streptavidin-HRP followed by TMB or other colorimetric HRP substrate.

e) Finally, the half maximal inhibitory concentration (IC50) of your compound to IL-13 R alpha 2: IL-13 binding will be determined by comparing OD readings among different experimental groups.

应用说明(Application

This kit is developed for screening for inhibitors of human IL-13 binding to human IL-13RA2.

It is for research use only.

重构方法(Reconstitution

Please see Certificate of Analysis for details of reconstitution instruction and specific concentration.

存储(Storage

Unopened kit should be stored at 2°C-8°C upon receiving. Find the expiration date on the outside packaging and do not use reagents past their expiration date.

The opened kit should be stored per components table. The shelf life is 30 days from the date of opening.

2.jpg

IL-13 ELISA Kit;IL-13试剂盒;IL-13 ELISA试剂盒;ACRO;百普赛斯;

公司简介

百普赛斯集团ACROBiosystems Group(股票代码:301080)是成立于2010年的跨国生物科技公司,是为全球生物医药、健康产业领域提供关键生物试剂产品及解决方案的行业平台型基石企业。2021年在创业板上市。百普赛斯集团业务遍布全球,横跨亚洲、北美洲、欧洲,在中国、美国、瑞士等12个城市设有办公室、研发中心及生产基地。目前累计服务客户超6000家,与全球Top 20医药企业均建立了长期、稳定的合作伙伴关系。集团旗下拥有品牌ACROBiosystems百普赛斯、bioSeedin柏思荟、Condense Capital垦拓资本和ACRODiagnostics百斯医学等。

成立日期 (15年)
注册资本 8000万人民币
员工人数 500人以上
年营业额 ¥ 1亿以上
经营模式 工厂,试剂
主营行业 医药中间体,原料药,激素类,氨基糖苷类,中枢神经系统用药

IL-13试剂盒相关厂家报价

内容声明
拨打电话 立即询价